236 related articles for article (PubMed ID: 19695418)
1. A hundred (and one) graphs tell only part of the story.
Silbergleit R
Ann Emerg Med; 2009 Sep; 54(3):342-3. PubMed ID: 19695418
[No Abstract] [Full Text] [Related]
2. A graphic reanalysis of the NINDS Trial.
Hoffman JR; Schriger DL
Ann Emerg Med; 2009 Sep; 54(3):329-36, 336.e1-35. PubMed ID: 19464756
[TBL] [Abstract][Full Text] [Related]
3. Response to "A graphic reanalysis of the NINDS Trial".
Dewey HM; Churilov L; Blacker D; Bladin C; Davis SM; Donnan GA; Gates P; Gerraty RP; Hand P; Levi C; Lindley RI; Markus R; Read S
Ann Emerg Med; 2010 Feb; 55(2):227-9; author reply 229. PubMed ID: 20116035
[No Abstract] [Full Text] [Related]
4. Thrombolysis in stroke: still not ready for community hospital use by emergency physicians.
McNamara RM
Ann Emerg Med; 2009 Sep; 54(3):339-41. PubMed ID: 19695417
[No Abstract] [Full Text] [Related]
5. Emergency physician survey: recombinant tissue plasminogen activator for stroke.
Mann J
Ann Emerg Med; 2006 Oct; 48(4):476; author reply 477. PubMed ID: 16997689
[No Abstract] [Full Text] [Related]
6. Testing new ideas: is a picture worth a thousand words?
Yealy DM; Callaham ML
Ann Emerg Med; 2009 Sep; 54(3):337-8. PubMed ID: 19695416
[No Abstract] [Full Text] [Related]
7. Influence of the stroke code activation source on the outcome of acute ischemic stroke patients.
Whitcomb DS
Neurology; 2009 May; 72(19):1709; author reply 1710. PubMed ID: 19433750
[No Abstract] [Full Text] [Related]
8. Beyond subgroup analysis: improving the clinical interpretation of treatment effects in stroke research.
Lu M; Lyden PD; Brott TG; Hamilton S; Broderick JP; Grotta JC
J Neurosci Methods; 2005 Apr; 143(2):209-16. PubMed ID: 15814153
[TBL] [Abstract][Full Text] [Related]
9. Be careful when extrapolating trial data to real life.
Dudley N
BMJ; 2003 Oct; 327(7418):812. PubMed ID: 14525900
[No Abstract] [Full Text] [Related]
10. Stroking the data: re-analysis of the NINDS trial.
Magid D; Naviaux N; Wears RL
Ann Emerg Med; 2005 Apr; 45(4):385-7. PubMed ID: 15795716
[No Abstract] [Full Text] [Related]
11. Can the therapeutic window for tissue plasminogen activator be extended to 6 hours after stroke onset?
Alexandrov AV
Nat Clin Pract Cardiovasc Med; 2005 Jul; 2(7):342-3. PubMed ID: 16265558
[No Abstract] [Full Text] [Related]
12. Alteplase for stroke. Financial information is needed to ensure objectivity.
Solomon RC
BMJ; 2002 Jun; 324(7353):1581; author reply 1581. PubMed ID: 12092607
[No Abstract] [Full Text] [Related]
13. Response to: "A graphic reanalysis of the NINDS Trial".
Saver JL; Gornbein J; Starkman S
Ann Emerg Med; 2010 Feb; 55(2):226-7; author reply 229. PubMed ID: 20116034
[No Abstract] [Full Text] [Related]
14. tPA for acute stroke: balancing baseline imbalances.
Mann J
CMAJ; 2002 Jun; 166(13):1651-2; author reply 1652-3. PubMed ID: 12126317
[No Abstract] [Full Text] [Related]
15. Use of MRI in the identification and treatment of early ischemic stroke lesions.
O'Rourke F; Akhtar N; Emery D; Shuaib A
CMAJ; 2004 Feb; 170(3):335-6. PubMed ID: 14757667
[No Abstract] [Full Text] [Related]
16. Emergency physician survey: recombinant tissue plasminogen activator for stroke.
Walsh M; Fromm G
Ann Emerg Med; 2006 Mar; 47(3):297. PubMed ID: 16492504
[No Abstract] [Full Text] [Related]
17. [Use of fibrinolytic agents during surgical treatment for submacular hemorrhages of various etiology].
Sosnovskiĭ VV; Sdobnikova SV
Vestn Oftalmol; 2008; 124(6):47-51. PubMed ID: 19205404
[No Abstract] [Full Text] [Related]
18. Alteplase for acute stroke revisited: the first 10 years.
Lyden PD; Lees KR; Davis SM
Lancet Neurol; 2006 Sep; 5(9):722-4. PubMed ID: 16914399
[No Abstract] [Full Text] [Related]
19. Thrombolysis, community hospitals, and primary stroke center.
Jeng JS
Acta Neurol Taiwan; 2009 Mar; 18(1):1-2. PubMed ID: 19537567
[No Abstract] [Full Text] [Related]
20. Acute ischemic stroke: Not a moment to lose.
Miller J; Mink J
Nursing; 2009 May; 39(5):37-42; quiz 42-3. PubMed ID: 19395934
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
